Literature DB >> 17053408

Arterial grafting for myocardial revascularization: how better is it?

Enrico Riccardo Ferrari1, Ludwig Karl von Segesser.   

Abstract

PURPOSE OF REVIEW: Arterial conduits are becoming popular in cardiac surgery. Clinical studies and long-term follow-ups have proven that this technique provides satisfactory long-lasting results. The purpose of this review is to give an overview of the main articles from recent literature and compare the latest results. RECENT
FINDINGS: Arterial conduits are currently used in cardiac surgery and clinical follow-ups are confirming some advantages in performing multiple arterial revascularization compared to the saphenous vein and the mammary artery. Mid-term follow-ups are encouraging the use of the radial artery as the second conduit of choice after the internal mammary artery. Moreover, off-pump cardiac surgery is an alternative to perform extensive myocardial revascularization in selected patients. Use of in-situ mammary arteries and off-pump surgery has already been described as the ideal solution to guarantee the 'no touch aorta technique'. Recent results lead us to use the radial artery and the gastroepiploic artery as complement composite grafts to perform total arterial myocardial revascularization during off-pump coronary surgery.
SUMMARY: Arterial grafting provides satisfactory results. The second graft of choice after the mammary artery is the radial artery, but long-term results are still not available. To reduce the risk of major neurological complications, selected patients benefit from off-pump arterial revascularization.

Entities:  

Mesh:

Year:  2006        PMID: 17053408     DOI: 10.1097/01.hco.0000245737.62959.e3

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

1.  Computationally optimizing the compliance of multilayered biomimetic tissue engineered vascular grafts.

Authors:  Ehab Akram Tamimi; Diana Catalina Ardila; Burt D Ensley; Robert S Kellar; Jonathan Vande Geest
Journal:  J Biomech Eng       Date:  2019-02-19       Impact factor: 2.097

2.  Total arterial grafting is associated with improved clinical outcomes compared to conventional myocardial revascularization at 10 years follow-up.

Authors:  Gianluigi Bisleri; Lorenzo Di Bacco; Laura Giroletti; Claudio Muneretto
Journal:  Heart Vessels       Date:  2016-05-03       Impact factor: 2.037

3.  Implantation study of small-caliber "biotube" vascular grafts in a rat model.

Authors:  Masashi Yamanami; Hatsue Ishibashi-Ueda; Akihide Yamamoto; Hidehiro Iida; Taiji Watanabe; Keiichi Kanda; Hitoshi Yaku; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-11-29       Impact factor: 1.731

4.  Vasodilatory Efficacy and Impact of Papaverine on Endothelium in Radial Artery Predilatation for CABG Surgery: in Search for Optimal Concentration.

Authors:  Piotr Węgrzyn; Grzegorz Lis; Paweł Rudzinski; Jacek Piatek; Grazyna Pyka-Fosciak; Ryszard Korbut; Boguslaw Kapelak; Krzysztof Bartus; Radoslaw Litwinowicz
Journal:  Braz J Cardiovasc Surg       Date:  2018 Nov-Dec

5.  Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae.

Authors:  Manabu Itoh; Koichi Nakayama; Ryo Noguchi; Keiji Kamohara; Kojirou Furukawa; Kazuyoshi Uchihashi; Shuji Toda; Jun-Ichi Oyama; Koichi Node; Shigeki Morita
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

Review 6.  The cardiovascular system and the biochemistry of grafts used in heart surgery.

Authors:  Suna Aydin; Suleyman Aydin; Mehmet Nesimi Eren; Ibrahim Sahin; Musa Yilmaz; Mehmet Kalayci; Orhan Gungor
Journal:  Springerplus       Date:  2013-11-16

7.  Gigantic aneurysm of a venous bypass graft causing superior vena cava syndrome.

Authors:  Karol S Buszkiewicz; Paweł Bugajski; Ryszard Kąsinowski; Jaromir Furmaniuk; Janusz Rzeźniczak; Tomasz Poprawka; Ireneusz Jedliński; Krzysztof Greberski; Ryszard Kalawski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.